Gallic acid ameliorates renal functions by inhibiting the activation of p38 MAPK in experimentally induced type 2 diabetic rats and cultured rat proximal tubular epithelial cells

Chemico-Biological Interactions

Volumn 240, Issue , 2015, Pages 292-303

  Ahad, Amjid ^a   Ahsan, Haseeb ^b   Mujeeb, Mohd ^c   Siddiqui, Waseem Ahmad ^a  

^a HAMDARD UNIVERSITY   (India)

^b JAMIA MILLIA ISLAMIA CENTRAL UNIVERSITY   (India)

^c HAMDARD UNIVERSITY   (India)

Author keywords

Diabetic nephropathy; Gallic acid; Hyperglycemia; Inflammation; Oxidative stress; p38 MAPK

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CREATININE; GALLIC ACID; GLUCOSE; GLUTATHIONE; HEMOGLOBIN A1C; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; MITOGEN ACTIVATED PROTEIN KINASE P38; NITROGEN; SUPEROXIDE DISMUTASE; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; UREA;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CYTOKINE PRODUCTION; DIABETIC NEPHROPATHY; ENZYME ACTIVATION; ENZYME REPRESSION; EPITHELIUM CELL; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; HISTOPATHOLOGY; IN VITRO STUDY; IN VIVO STUDY; KIDNEY PROXIMAL TUBULE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; PROTEINURIA; RAT; RENAL PROTECTION; SIGNAL TRANSDUCTION; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; TREATMENT DURATION; TREATMENT RESPONSE; UREA NITROGEN BLOOD LEVEL; ANIMAL; ANTAGONISTS AND INHIBITORS; CELL CULTURE; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; DISEASE MODEL; DRUG EFFECTS;

ANIMALS; CELLS, CULTURED; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; DISEASE MODELS, ANIMAL; EPITHELIAL CELLS; GALLIC ACID; KIDNEY TUBULES, PROXIMAL; P38 MITOGEN-ACTIVATED PROTEIN KINASES; RATS;

EID: 84941559657     PISSN: 00092797     EISSN: 18727786     Source Type: Journal    
DOI: 10.1016/j.cbi.2015.08.026     Document Type: Article

References (113)

1. A.T. Reutens, and R.C. Atkins Epidemiology of diabetic nephropathy Contrib. Nephrol. 170 2011 1 7
2. J.F. Navarro-Gonzalez, C. Mora-Fernandez, M. Muros de Fuentes, and J. Garcia-Perez Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathy Nat. Rev. Nephrol. 7 2011 327 340
3. A.M. Badger, A.K. Roshak, M.N. Cook, T.M. Newman-Tarr, B.A. Swift, K. Carlson, J.R. Connor, J.C. Lee, M. Gowen, M.W. Lark, and S. Kumar Differential effects of SB 242235, a selective p38 mitogen-activated protein kinase inhibitor, on IL-1 treated bovine and human cartilage/chondrocyte cultures Osteoarthr. Cartil. 8 2000 434 443
4. Z. Guan, S.Y. Buckman, A.P. Pentland, D.J. Templeton, and A.R. Morrison Induction of cyclooxygenase-2 by the activated MEKK1 - > SEK1/MKK4 - > p38 mitogen-activated protein kinase pathway J. Biol. Chem. 273 1998 12901 12908
5. Z. Guan, S.Y. Buckman, L.D. Springer, and A.R. Morrison Regulation of cyclooxygenase-2 by the activated p38 MAPK signaling pathway Adv. Exp. Med. Biol. 469 1999 9 15
6. S. Saccani, S. Pantano, and G. Natoli p38-dependent marking of inflammatory genes for increased NF-kappa B recruitment Nat. Immunol. 3 2002 69 75
7. J.A. Nick, S.K. Young, K.K. Brown, N.J. Avdi, P.G. Arndt, B.T. Suratt, M.S. Janes, P.M. Henson, and G.S. Worthen Role of p38 mitogen-activated protein kinase in a murine model of pulmonary inflammation J. Immunol. 164 2000 2151 2159
8. E.B. Haddad, M. Birrell, K. McCluskie, A. Ling, S.E. Webber, M.L. Foster, and M.G. Belvisi Role of p38 MAP kinase in LPS-induced airway inflammation in the rat Br. J. Pharmacol. 132 2001 1715 1724
9. J.K. Kim, A. Pedram, M. Razandi, and E.R. Levin Estrogen prevents cardiomyocyte apoptosis through inhibition of reactive oxygen species and differential regulation of p38 kinase isoforms J. Biol. Chem. 281 2006 6760 6767
10. D.G. Perregaux, D. Dean, M. Cronan, P. Connelly, and C.A. Gabel Inhibition of interleukin-1 beta production by SKF86002: evidence of two sites of in vitro activity and of a time and system dependence Mol. Pharmacol. 48 1995 433 442
11. G.V. Johnson, and C.D. Bailey The p38 MAP kinase signaling pathway in Alzheimer's disease Exp. Neurol. 183 2003 263 268
12. E. Hollenbach, M. Neumann, M. Vieth, A. Roessner, P. Malfertheiner, and M. Naumann Inhibition of p38 MAP kinase- and RICK/NF-kappaB-signaling suppresses inflammatory bowel disease FASEB J. 18 2004 1550 1552
13. Y. Du, J. Tang, G. Li, L. Berti-Mattera, C.A. Lee, D. Bartkowski, D. Gale, J. Monahan, M.R. Niesman, G. Alton, and T.S. Kern Effects of p38 MAPK inhibition on early stages of diabetic retinopathy and sensory nerve function Investig. Ophthalmol. Vis. Sci. 51 2010 2158 2164
14. N. Sakai, T. Wada, K. Furuichi, Y. Iwata, K. Yoshimoto, K. Kitagawa, S. Kokubo, M. Kobayashi, S. Takeda, H. Kida, K. Kobayashi, N. Mukaida, K. Matsushima, and H. Yokoyama p38 MAPK phosphorylation and NF-kappa B activation in human crescentic glomerulonephritis Nephrol. Dial. Transpl. 17 2002 998 1004
15. L. Adhikary, F. Chow, D.J. Nikolic-Paterson, C. Stambe, J. Dowling, R.C. Atkins, and G.H. Tesch Abnormal p38 mitogen-activated protein kinase signalling in human and experimental diabetic nephropathy Diabetologia 47 2004 1210 1222
16. H. Chen, S. Brahmbhatt, A. Gupta, and A.C. Sharma Duration of streptozotocin-induced diabetes differentially affects p38-mitogen-activated protein kinase (MAPK) phosphorylation in renal and vascular dysfunction Cardiovasc. Diabetol. 4 2005 3
17. H.M. Chen, Y.C. Wu, Y.C. Chia, F.R. Chang, H.K. Hsu, and Y.C. Hsieh Gallic acid, a major component of Toona sinensis leaf extracts, contains a ROS mediated anti-cancer activity in human prostate cancer cells Cancer Lett. 286 2009 161 171
18. J. D'Souza, P. D'Souza, F. Fazal, A. Kumar, H.P. Bhat, and M.S. Baliga Anti-diabetic effects of the Indian indigenous fruit Emblica officinalis Gaertn: active constituents and modes of action Food Funct. 5 4 2014 635 644
19. H.L. Huang, C.C. Lin, K.C. Jeng, P.W. Yao, L.T. Chuang, and S.L. Kuo Fresh green tea and gallic acid ameliorates oxidative stress in kainic acid induced status epilepticus J. Agric. Food Chem. 60 2012 2328 2336
20. M. Hidalgo, S. Martin-Santamaria, I. Recio, C. Sanchez-Moreno, B. de Pascual-Teresa, and G. Rimbach Potential anti-inflammatory, anti-adhesive, anti/estrogenic, and angiotensin-converting enzyme inhibitory activities of anthocyanins and their gut metabolites Genes. Nutr. 7 2 2012 295 306
21. H.H. Ho, C.S. Chang, W.C. Ho, S.Y. Liao, W.L. Lin, and C.J. Wang Gallic acid inhibits gastric cancer cells metastasis and invasive growth via increased expression of RhoB, downregulation of AKT/small GTPase signals and inhibition of NF-kappaB activity Toxicol. Appl. Pharmacol. 266 2013 76 85
22. S. Habtemariam Flavonoids as inhibitors or enhancers of the cytotoxicity of tumor necrosis factor-alpha in L-929 tumor cells J. Nat. Prod. 60 1997 775 778
23. S.M. Nabavi, S. Habtemariam, S.F. Nabavi, A. Sureda, M. Daglia, A.H. Moghaddam, and M.A. Amani Protective effect of gallic acid isolated from Peltiphyllum peltatum against sodium fluoride-induced oxidative stress in rat's kidney Mol. Cell Biochem. 372 2013 233 239
24. V.R. Punithavathi, P. Stanely Mainzen Prince, M.R. Kumar, and C.J. Selvakumari Protective effects of gallic acid on hepatic lipid peroxide metabolism, glycoprotein components and lipids in streptozotocin-induced type II diabetic Wistar rats J. Biochem. Mol. Toxicol. 25 2011 68 76
25. K. Liu, S. Hu, B. Chan, E. Wat, C. Lau, K. Hon, K. Fung, P. Leung, P. Hui, C. Lam, and C. Wong Anti-inflammatory and anti-allergic activities of pentaherb formula, moutan cortex (Danpi) and gallic acid Molecules 18 2013 2483
26. K.C. Choi, Y.H. Lee, M.G. Jung, S.H. Kwon, M.J. Kim, and W.J. Jun Gallic acid suppresses lipopolysaccharide-induced nuclear factor-jB signaling by preventing rela acetylation in A549 lung cancer cells Mol. Cancer Res. 7 2009 2011 2021
27. C.Y. Hsiang, Y.C. Hseu, Y.C. Chang, K.J. Kumar, T.Y. Ho, and H.L. Yang Toona sinensis and its major bioactive compound gallic acid inhibit LPS-induced inflammation in nuclear factor-kappaB transgenic mice as evaluated by in vivo bioluminescence imaging Food Chem. 136 2013 426 434
28. OECD Repeated Dose 28day Oral Toxicity Study in Rodents. OECD Guideline 407 for the Testing of Chemicals 1995 Organization for Economic Cooperation and Development Paris
29. C. Ghai A Text Book of Practical Physiology 1990 Jaypee Brothers (P) Ltd. India 119 120
30. M.M. Bradford A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding Anal. Biochem. 72 1976 248 254
31. H. Ohkawa, N. Ohishi, and K. Yagi Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction Anal. Biochem. 95 1979 351 358
32. S. Marklund, and G. Marklund Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase Eur. J. Biochem. 47 1974 469 474
33. A. Claiborne Catalase activity R.A. Greenwald, CRC Handbook of Methods in Oxygen Radical Research 1985 CRC Press Boca Raton 283 284
34. R.S. Danda, N.M. Habiba, H. Rincon-Choles, B.K. Bhandari, J.L. Barnes, H.E. Abboud, and P.E. Pergola Kidney involvement in a nongenetic rat model of type 2 diabetes Kidney Int. 68 2005 2562 2571
35. D. Braham, and P. Tinder Estimation of glucose. Glucose oxidase method Analyst 97 1972 142 144
36. D.M. Nathan, D.E. Singer, K. Hurxthal, and J.D. Goodson The clinical information value of the glycosylated hemoglobin assay N. Engl. J. Med. 310 1984 341 346
37. L. Arreola-Mendoza, J.L. Reyes, E. Melendez, D. Martin, M.C. Namorado, E. Sanchez, and L.M. Del Razo Alpha-tocopherol protects against the renal damage caused by potassium dichromate Toxicology 218 2006 237 246
38. T. Mosmann Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays J. Immunol. Methods 65 1983 55 63
39. P.G. Chandak, A.B. Gaikwad, and K. Tikoo Gallotannin ameliorates the development of streptozotocin-induced diabetic nephropathy by preventing the activation of PARP Phytother. Res. 23 2009 72 77
40. A. Baradaran, H. Nasri, M. Nematbakhsh, and M. Rafieian-Kopaei Antioxidant activity and preventive effect of aqueous leaf extract of aloe vera on gentamicin-induced nephrotoxicity in male Wistar rats Clin. Ter. 165 2014 7 11
41. I.J. Kade, and J.B. Rocha Gallic acid modulates cerebral oxidative stress conditions and activities of enzyme-dependent signaling systems in streptozotocin-treated rats Neurochem. Res. 38 2013 761 771
42. M. Igarashi, H. Wakasaki, N. Takahara, H. Ishii, Z.Y. Jiang, T. Yamauchi, K. Kuboki, M. Meier, C.J. Rhodes, and G.L. King Glucose or diabetes activates p38 mitogen-activated protein kinase via different pathways J. Clin. Investig. 103 1999 185 195
43. R. Komers, J.N. Lindsley, T.T. Oyama, D.M. Cohen, and S. Anderson Renal p38 MAP kinase activity in experimental diabetes Lab. Investig. 87 2007 548 558
44. M. Igarashi, A. Hirata, H. Yamaguchi, N. Sugae, Y. Kadomoto-Antsuki, H. Nozaki, Y. Jimbu, and M. Tominaga Characterization of activation of MAP kinase superfamily in vasculature from diabetic rats J. Atheroscler. Thromb. 14 2007 235 244
45. S. Agthong, and D.R. Tomlinson Inhibition of p38 MAP kinase corrects biochemical and neurological deficits in experimental diabetic neuropathy Ann. N. Y. Acad. Sci. 973 2002 359 362
46. W.M. Macfarlane, S.B. Smith, R.F. James, A.D. Clifton, Y.N. Doza, P. Cohen, and K. Docherty The p38/reactivating kinase mitogen-activated protein kinase cascade mediates the activation of the transcription factor insulin upstream factor 1 and insulin gene transcription by high glucose in pancreatic beta-cells J. Biol. Chem. 272 1997 20936 20944
47. W.A. Wilmer, C.L. Dixon, and C. Hebert Chronic exposure of human mesangial cells to high glucose environments activates the p38 MAPK pathway Kidney Int. 60 2001 858 871
48. Y. Du, J. Tang, G. Li, L. Berti-Mattera, C.A. Lee, D. Bartkowski, D. Gale, J. Monahan, M.R. Niesman, G. Alton, and T.S. Kern Effects of p38 MAPK inhibition on early stages of diabetic retinopathy and sensory nerve function Investig. Ophthalmol. Vis. Sci. 51 2010 2158 2164
49. A.K. Lim, and G.H. Tesch Inflammation in diabetic nephropathy Mediat. Inflamm. 2012 2012 146154
50. T. Force, and J.V. Bonventre Growth factors and mitogen-activated protein kinases Hypertension 31 1998 152 161
51. W. Tian, Z. Zhang, and D.M. Cohen MAPK signaling and the kidney Am. J. Physiol. Ren. Physiol. 279 2000 F593 F604
52. S. Mezzano, C. Aros, A. Droguett, M.E. Burgos, L. Ardiles, C. Flores, H. Schneider, M. Ruiz-Ortega, and J. Egido NF-kappaB activation and overexpression of regulated genes in human diabetic nephropathy Nephrol. Dial. Transpl. 19 2004 2505 2512
53. D.C. Fitzgerald, K.G. Meade, A.N. McEvoy, L. Lillis, E.P. Murphy, D.E. MacHugh, and A.W. Baird Tumour necrosis factor-alpha (TNF-alpha) increases nuclear factor kappaB (NFkappaB) activity in and interleukin-8 (IL-8) release from bovine mammary epithelial cells Vet. Immunol. Immunopathol. 116 2007 59 68
54. J.S. Nam, M.H. Cho, G.T. Lee, J.S. Park, C.W. Ahn, B.S. Cha, S.K. Lim, K.R. Kim, H.J. Ha, and H.C. Lee The activation of NF-κB and AP-1 in peripheral blood mononuclear cells isolated from patients with diabetic nephropathy Diabetes Res. Clin. Pract. 81 2008 25 32
55. G. Hasegawa, K. Nakano, and M. Kondo Role of TNF and IL-1 in the development of diabetic nephropathy Nefrologia 5 1995 1 4
56. B. Yang, A. Hodgkinson, P.J. Oates, B.A. Millward, and A.G. Demaine High glucose induction of DNA-binding activity of the transcription factor NFκB in patients with diabetic nephropathy Biochim. Biophys. Acta (BBA) Mol. Basis Dis. 1782 2008 295 302
57. J. Saklatvala The p38 MAP kinase pathway as a therapeutic target in inflammatory disease Curr. Opin. Pharmacol. 4 2004 372 377
58. A.S. Lal, A.D. Clifton, J. Rouse, A.W. Segal, and P. Cohen Activation of the neutrophil NADPH oxidase is inhibited by SB 203580, a specific inhibitor of SAPK2/p38 Biochem. Biophys. Res. Commun. 259 1999 465 470
59. P. Fuentes-Prior, and G.S. Salvesen The protein structures that shape caspase activity, specificity, activation and inhibition Biochem. J. 384 2004 201 232
60. W. Bao, D.J. Behm, S.S. Nerurkar, Z. Ao, R. Bentley, R.C. Mirabile, D.G. Johns, T.N. Woods, C.P. Doe, R.W. Coatney, J.F. Ohlstein, S.A. Douglas, R.N. Willette, and T.L. Yue Effects of p38 MAPK Inhibitor on angiotensin II-dependent hypertension, organ damage, and superoxide anion production J. Cardiovasc. Pharmacol. 49 2007 362 368
61. B.K. Yoo, J.W. Choi, C.Y. Shin, S.J. Jeon, S.J. Park, J.H. Cheong, S.Y. Han, J.R. Ryu, M.R. Song, and K.H. Ko Activation of p38 MAPK induced peroxynitrite generation in LPS plus IFN-gamma-stimulated rat primary astrocytes via activation of iNOS and NADPH oxidase Neurochem. Int. 52 2008 1188 1197
62. S. Shelbaya, H. Amer, S. Seddik, A.A. Allah, I.M. Sabry, T. Mohamed, and M. El Mosely Study of the role of interleukin-6 and highly sensitive C-reactive protein in diabetic nephropathy in type 1 diabetic patients Eur. Rev. Med. Pharmacol. Sci. 16 2012 176 182
63. J. Pfeilschifter, W. Pignat, K. Vosbeck, and F. Marki Interleukin 1 and tumor necrosis factor synergistically stimulate prostaglandin synthesis and phospholipase A2 release from rat renal mesangial cells Biochem. Biophys. Res. Commun. 159 1989 385 394
64. M. Dalla Vestra, M. Mussap, P. Gallina, M. Bruseghin, A.M. Cernigoi, A. Saller, M. Plebani, and P. Fioretto Acute-phase markers of inflammation and glomerular structure in patients with type 2 diabetes J. Am. Soc. Nephrol. 16 2005 S78 S82
65. N. Yamagishi, K. Nakayama, T. Wakatsuki, and T. Hatayama Characteristic changes of stress protein expression in streptozotocin-induced diabetic rats Life Sci. 69 2001 2603 2609
66. I.S. Park, H. Kiyomoto, S.L. Abboud, and H.E. Abboud Expression of transforming growth factor-beta and type IV collagen in early streptozotocin-induced diabetes Diabetes 46 1997 473 480
67. B.Y. Chin, A. Mohsenin, S.X. Li, A.M. Choi, and M.E. Choi Stimulation of pro-alpha(1)(I) collagen by TGF-beta(1) in mesangial cells: role of the p38 MAPK pathway Am. J. Physiol. Ren. Physiol. 280 2001 F495 F504
68. H. Suzuki, K. Uchida, K. Nitta, and H. Nihei Role of mitogen-activated protein kinase in the regulation of transforming growth factor-beta-induced fibronectin accumulation in cultured renal interstitial fibroblasts Clin. Exp. Nephrol. 8 2004 188 195
69. A. Ahad, A.A. Ganai, M. Mujeeb, and W.A. Siddiqui Ellagic acid, an NF-κB inhibitor, ameliorates renal function in experimental diabetic nephropathy Chem. Biol. Interact. 219 2014 64 75
70. A. Ahad, A.A. Ganai, M. Mujeeb, and W.A. Siddiqui Chrysin, an anti-inflammatory molecule, abrogates renal dysfunction in type 2 diabetic rats Toxicol. Appl. Pharmacol. 279 2014 1 7
71. A. Ahad, M. Mujeeb, H. Ahsan, and W.A. Siddiqui Prophylactic effect of baicalein against renal dysfunction in type 2 diabetic rats Biochimie 106 2014 101 110
72. S. Siddiqui, H. Ahsan, M.R. Khan, and W.A. Siddiqui Protective effects of tocotrienols against lipid-induced nephropathy in experimental type-2 diabetic rats by modulation in TGF-β expression Toxicol. Appl. Pharmacol. 273 2013 314 324
73. Y.S. Kim, J. Kim, C.S. Kim, E.J. Sohn, Y.M. Lee, I.H. Jeong, H. Kim, D.S. Jang, and J.S. Kim KIOM-79, an Inhibitor of AGEs-protein cross-linking, prevents progression of nephropathy in zucker diabetic fatty rats Evid. Based Complement. Altern. Med. 2011 2011 761859
74. V.R. Punithavathi, P.S. Prince, R. Kumar, and J. Selvakumari Antihyperglycemic, antilipid peroxidative and antioxidant effects of gallic acid on streptozotocin induced diabetic Wistar rats Eur. J. Pharmacol. 650 2011 465 471
75. E.J. Bak, J. Kim, S. Jang, G.H. Woo, H.G. Yoon, Y.J. Yoo, and J.H. Cha Gallic acid improves glucose tolerance and triglyceride concentration in diet-induced obesity mice Scand. J. Clin. Lab. Investig. 73 2013 607 614
76. N. Bektas, and Y. Ozturk Effect of phenolic acids on functions of rat aorta, vas deferens and on metabolic changes in streptozotocin-induced diabetes Indian J. Pharmacol. 44 2012 184 188
77. W. Benalla, S. Bellahcen, and M. Bnouham Antidiabetic medicinal plants as a source of alpha glucosidase inhibitors Curr. Diabetes Rev. 6 2010 247 254
78. N.D. Das, K.H. Jung, J.H. Park, M.A. Mondol, H.J. Shin, H.S. Lee, K.S. Park, M.R. Choi, K.S. Kim, M.S. Kim, S.R. Lee, and Y.G. Chai Terminalia chebula extract acts as a potential NF-kappaB inhibitor in human lymphoblastic T cells Phytother. Res. 25 2011 927 934
79. C.M. Olson, M.N. Hedrick, H. Izadi, T.C. Bates, E.R. Olivera, and J. Anguita p38 mitogen-activated protein kinase controls NF-kappaB transcriptional activation and tumor necrosis factor alpha production through RelA phosphorylation mediated by mitogen- and stress-activated protein kinase 1 in response to Borrelia burgdorferi antigens Infect. Immun. 75 2007 270 277
80. D.J. Conrad, and M. Lu Regulation of human 12/15-lipoxygenase by Stat6-dependent transcription Am. J. Respir. Cell Mol. Biol. 22 2000 226 234
81. R. Natarajan, W. Bai, V. Rangarajan, N. Gonzales, J.L. Gu, L. Lanting, and J.L. Nadler Platelet-derived growth factor BB mediated regulation of 12-lipoxygenase in porcine aortic smooth muscle cells J. Cell Physiol. 169 1996 391 400
82. P. Pu, X.A. Wang, M. Salim, L.H. Zhu, L. Wang, K.J. Chen, J.F. Xiao, W. Deng, H.W. Shi, H. Jiang, and H.L. Li Baicalein, a natural product, selectively activating AMPKalpha(2) and ameliorates metabolic disorder in diet-induced mice Mol. Cell Endocrinol. 362 2012 128 138
83. H. Fujita, S. Omori, K. Ishikura, M. Hida, and M. Awazu ERK and p38 mediate high-glucose-induced hypertrophy and TGF-beta expression in renal tubular cells Am. J. Physiol. Ren. Physiol. 286 2004 F120 F126
84. M.S. Hayden, A.P. West, and S. Ghosh NF-κB and the immune response Oncogene 25 2006 6758 6780
85. J. Wada, and H. Makino Inflammation and the pathogenesis of diabetic nephropathy Clin. Sci. (Lond) 124 2013 139 152
86. M. Dhingra, S. Dhingra, R. Chadha, T. Singh, and M. Karan Design, synthesis, physicochemical, and pharmacological evaluation of gallic acid esters as non-ulcerogenic and gastroprotective anti-inflammatory agents Med. Chem. Res. 23 2014 4771 4788
87. H. Deng, and Y. Fang Anti-inflammatory gallic acid and wedelolactone are G protein-coupled receptor-35 agonists Pharmacology 89 2012 211 219
88. M. Amaravani, N. Prasad, and V. Ramakrishna COX-2 structural analysis and docking studies with gallic acid structural analogues SpringerPlus 1 2012 58
89. M. Karin, and F.R. Greten NF-kappaB: linking inflammation and immunity to cancer development and progression Nat. Rev. Immunol. 5 2005 749 759
90. T. Nakamura, M. Fukui, I. Ebihara, S. Osada, I. Nagaoka, Y. Tomino, and H. Koide mRNA expression of growth factors in glomeruli from diabetic rats Diabetes 42 1993 450 456
91. J.F. Navarro, F.J. Milena, C. Mora, C. Leon, and J. Garcia Renal pro-inflammatory cytokine gene expression in diabetic nephropathy: effect of angiotensin-converting enzyme inhibition and pentoxifylline administration Am. J. Nephrol. 26 2006 562 570
92. B. Baban, J.Y. Liu, and M.S. Mozaffari Endoplasmic reticulum stress response and inflammatory cytokines in type 2 diabetic nephropathy: Role of indoleamine 2,3-dioxygenase and programmed death-1 Exp. Mol. Pathol. 94 2 2013 343 351
93. V. Lopez-Parra, B. Mallavia, J. Egido, and C. Gomez-Guerrero Immunoinflammation in diabetic nephropathy: molecular mechanisms and therapeutic options D.J. Chan, Diabetic Nephropathy 2012 InTech Croatia, Europe
94. K.C. Choi, Y.H. Lee, M.G. Jung, S.H. Kwon, M.J. Kim, W.J. Jun, J. Lee, J.M. Lee, and H.G. Yoon Gallic acid suppresses lipopolysaccharide-induced nuclear factor-kappaB signaling by preventing RelA acetylation in A549 lung cancer cells Mol. Cancer Res. 7 2009 2011 2021
95. S.H. Kim, C.D. Jun, K. Suk, B.J. Choi, H. Lim, S. Park, S.H. Lee, H.Y. Shin, D.K. Kim, and T.Y. Shin Gallic acid inhibits histamine release and pro-inflammatory cytokine production in mast cells Toxicol. Sci. 91 2006 123 131
96. P. Palatini Glomerular hyperfiltration: a marker of early renal damage in pre-diabetes and pre-hypertension Nephrol. Dial. Transplant. 27 5 2012 1708 1714
97. S. Tian, J. Tang, H. Liu, L. Wang, J. Shen, J. Li, and Y. Gan Propyl gallate plays a nephroprotective role in early stage of diabetic nephropathy associated with suppression of glomerular endothelial cell proliferation and angiogenesis Exp. Diabetes Res. 2012 2012 209567
98. C.C. Peng, C.L. Hsieh, H.E. Wang, J.Y. Chung, K.C. Chen, and R.Y. Peng Ferulic acid is nephro damaging while gallic acid is renal protective in long term treatment of chronic kidney disease Clin. Nutr. 31 2012 405 414
99. A.A. Elmarakby, and J.C. Sullivan Relationship between oxidative stress and inflammatory cytokines in diabetic nephropathy Cardiovasc Ther. 30 2012 49 59
100. H. Noh, and H. Ha Reactive oxygen species and oxidative stress Contrib. Nephrol. 170 2011 102 112
101. J.M. Forbes, M.T. Coughlan, and M.E. Cooper Oxidative stress as a major culprit in kidney disease in diabetes Diabetes 57 2008 1446 1454
102. S.A. Price, N.J. Gardiner, B. Duran-Jimenez, L.A. Zeef, I.G. Obrosova, and D.R. Tomlinson Thioredoxin interacting protein is increased in sensory neurons in experimental diabetes Brain Res. 1116 2006 206 214
103. D.O. Kim, K.W. Lee, H.J. Lee, and C.Y. Lee Vitamin C equivalent antioxidant capacity (VCEAC) of phenolic phytochemicals J. Agric. Food Chem. 50 2002 3713 3717
104. W. Kusirisin, S. Srichairatanakool, P. Lerttrakarnnon, N. Lailerd, M. Suttajit, C. Jaikang, and C. Chaiyasut Antioxidative activity, polyphenolic content and anti-glycation effect of some Thai medicinal plants traditionally used in diabetic patients Med. Chem. 5 2009 139 147
105. I.J. Kade, Y. Ogunbolude, J.P. Kamdem, and J.B. Rocha Influence of gallic acid on oxidative stress-linked streptozotocin-induced pancreatic dysfunction in diabetic rats J. Basic Clin. Physiol. Pharmacol. 2013 1 11
106. S. Nabavi, S. Habtemariam, S. Nabavi, A. Sureda, M. Daglia, A. Moghaddam, and M. Amani Protective effect of gallic acid isolated from Peltiphyllum peltatum against sodium fluoride-induced oxidative stress in rat's kidney Mol. Cell. Biochem. 372 2013 233 239
107. M. Canbek, G. Bayramoglu, H. Senturk, A.P. Oztopcu Vatan, M. Uyanoglu, E. Ceyhan, A. Ozen, B. Durmus, K. Kartkaya, and G. Kanbak The examination of protective effects of gallic acid against damage of oxidative stress during induced-experimental renal ischemia-reperfusion in experiment Bratisl. Lek. Listy 115 2014 557 562
108. S.L. Zhang, S.S. Tang, X. Chen, J.G. Filep, J.R. Ingelfinger, and J.S. Chan High levels of glucose stimulate angiotensinogen gene expression via the P38 mitogen-activated protein kinase pathway in rat kidney proximal tubular cells Endocrinology 141 2000 4637 4646
109. X. Cheng, W. Gao, Y. Dang, X. Liu, Y. Li, X. Peng, and X. Ye Both ERK/MAPK and TGF-Beta/Smad signaling pathways play a role in the kidney fibrosis of diabetic mice accelerated by blood glucose fluctuation J. Diabetes Res. 2013 2013 463740
110. R. Ramasamy, S.F. Yan, and A.M. Schmidt Receptor for age (RAGE): signaling mechanisms in the pathogenesis of diabetes and its complications Ann. N. Y. Acad. Sci. 1243 2011 88 102
111. K.C. Sourris, A.L. Morley, A. Koitka, P. Samuel, M.T. Coughlan, S.A. Penfold, M.C. Thomas, A. Bierhaus, P.P. Nawroth, H. Yamamoto, T.J. Allen, T. Walther, T. Hussain, M.E. Cooper, and J.M. Forbes Receptor for AGEs (RAGE) blockade may exert its renoprotective effects in patients with diabetic nephropathy via induction of the angiotensin II type 2 (AT2) receptor Diabetologia 53 2010 2442 2451
112. K.C. Sourris, and J.M. Forbes Interactions between advanced glycation end-products (AGE) and their receptors in the development and progression of diabetic nephropathy -are these receptors valid therapeutic targets Curr. Drug Targets 10 2009 42 50
113. A.C.K. Chung, H. Zhang, Y.-Z. Kong, J.-J. Tan, X.R. Huang, J.B. Kopp, and H.Y. Lan Advanced glycation end-products induce tubular CTGF via TGF-β-Independent Smad3 signaling J. Am. Soc. Nephrol. 21 2010 249 260